drugset / Trial / NCT00107757

Seasonal Allergic Rhinitis In Pediatric Subjects

NCT00107757

Phase 3 Completed 576 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.

Timeline

Start
2005-03
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified 50 ug Intranasal
Subject Fluticasone Furoate Other / unclassified 100 ug Intranasal